000 01464 a2200397 4500
005 20250518030222.0
264 0 _c20200406
008 202004s 0 0 eng d
022 _a1543-2165
024 7 _a10.5858/arpa.2018-0394-CP
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSurrey, Lea F
245 0 0 _aNext-Generation Sequencing (NGS) Methods Show Superior or Equivalent Performance to Non-NGS Methods on
_h[electronic resource]
260 _bArchives of pathology & laboratory medicine
_c08 2019
300 _a980-984 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aErbB Receptors
_xgenetics
650 0 4 _aGenetic Testing
_xmethods
650 0 4 _aHigh-Throughput Nucleotide Sequencing
_xmethods
650 0 4 _aHumans
650 0 4 _aLaboratory Proficiency Testing
_xmethods
650 0 4 _aMutation
650 0 4 _aNeoplasms
_xdiagnosis
650 0 4 _aProto-Oncogene Proteins B-raf
_xgenetics
650 0 4 _aProto-Oncogene Proteins p21(ras)
_xgenetics
650 0 4 _aReproducibility of Results
650 0 4 _aSensitivity and Specificity
700 1 _aOakley, Fredrick D
700 1 _aMerker, Jason D
700 1 _aLong, Thomas A
700 1 _aVasalos, Patricia
700 1 _aMoncur, Joel T
700 1 _aKim, Annette S
773 0 _tArchives of pathology & laboratory medicine
_gvol. 143
_gno. 8
_gp. 980-984
856 4 0 _uhttps://doi.org/10.5858/arpa.2018-0394-CP
_zAvailable from publisher's website
999 _c29471534
_d29471534